Risperidone-loaded long-acting injectable microspheres prepared by ultra-fine particle processing system

Chinese Journal of New Drugs

Volumn 21, Issue 7, 2012, Pages 795-799

  Fu, Han ^a,b   Wen, Xin Guo ^a   Wang, Zhou Hua ^a   Pan, Xin ^a   Wu, Chuan Bin ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Research and Development Center of Pharmaceutical Engineer   (China)

Author keywords

Long acting; Microspheres; Poly(D, L lactic co glycolic acid); Risperidone; Ultra fine particle processing system

Indexed keywords

MICROSPHERE; POLYGLACTIN; RISPERIDONE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; PARTICLE SIZE; ULTRA FINE PARTICLE PROCESSING SYSTEM;

EID: 84861774683     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. MUTHU M S, SINGH S. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation[J]. Nanomedicine(Lond), 2008, 3(3): 305-319.
2. FREIBERG S, ZHU X X. Polymer microspheres for controlled drug release[J]. Int J Pharm, 2004, 282(1-2): 1-18.
3. GOMBOTZ W, HEALY M, BROWN L. Very low temperature casting of controlled release microspheres: US, 5019400[P]. 1991-05-28.
4. HUNG L H, TEH S Y, JESTER J, et al. PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches[J]. Lab Chip, 2010, 10(14): 1820-1825.
5. 2010-09-01.
6. LEACH J. Comparison of Faxen's correction for a microsphere translating or rotating near a surface[J]. Phys Rev E, 2009, 79(2): 1539-3755.
7. BRECHTELSBAUER C, LEWIS N, OXLEY P, et al. Evaluation of a spinning disc reactor for continuous processing[J]. Org Process Res Dev, 2001, 5(1): 65-68.
8. BOODHOO K V K, JACHUCK R J. Process intensification: spinning disk reactor for styrene polymerisation[J]. Appl Therm Eng, 2000, 20(12): 1127-1146.
9. WEN X G, PENG X S, FU HAN, et al. Preparation and in vitro evaluation of silk fibroin micropheres produced by a novel ultra-fine particle processing system[J]. Int J Pharm, 2011, 416: 195-201.
10. SU Z, SUN F, SHI Y, et al. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D, L-lactide-co-glycolide) microsphere[J]. Chemm Phar Bull, 2009, 57(11): 1251-1256.
11. 2010, 19(22): 2066-2069.
12. MESENS J, MICHAEL E R, THOMAS J A. Microencapsulated 3-piperidinyl-substituted 1, 2-benzisoxazoles and 1, 2-benzisothiazoles: US, 6368632B1[P]. 2002-04-09.